LiP.K., SzetoC.C., PirainoB., BernardiniJ., FigueiredoA.E., GuptaA.On behalf of the International Society for Peritoneal Dialysis. Peritoneal dialysis–related infections recommendations: 2010 update.Perit Dial Int2010; 30: 393–423. [Erratum in: Perit Dial Int 2011; 31:512]
2.
OhK.H., KimS.G., KimJ.S., JungW., KimS.J., ShinY.Empiric therapy with cefazolin and ceftazidime (or aminoglycoside) is effective as the initial choice for the treatment of peritoneal dialysis related peritonitis.Korean J Nephrol2005; 24: 204–14.
3.
PirainoB., BernardiniJ., BrownE., FigueiredoA., JohnsonD.W., LyeW.C.ISPD position statement on reducing the risks of peritoneal dialysis–related infections.Perit Dial Int2011; 31: 614–30.
4.
LeeheyD.J., SzetoC.C., LiP.K.Peritonitis and exit site infection. In: Daugirdas JT, Blake PG, Ing TS. Handbook of Dialysis.4th ed.Philadelphia, PA: Lippincott Williams and Wilkins; 2007: 417–39.
5.
StrippoliG.F., TongA., JohnsonD., SchenaF.P., CraigJ.C.Catheter-related interventions to prevent peritonitis in peritoneal dialysis: a systematic review of randomized, controlled trials.J Am Soc Nephrol2004; 15: 2735–46.